91制片厂

The global Ethylene-vinyl Acetate (EVA) Infusion Bag market size is predicted to grow from US$ 856 million in 2025 to US$ 1274 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Ethylene-vinyl acetate infusion bag is used as intravenous (IV) bag, which helps to carry fluids in the patient"s body through the intravenous route. In addition, these bags can be used to carry vitamins, lipids, and oncology medications in patients. They are often transparent, which helps in easier visual assessment of the IV solution. Most ethylene-vinyl acetate infusion bags are UV-protected within the wavelength range of 170 nm to 520 nm. These bags are toxicologically harmless when compared to IV bags made using polyvinyl chloride (PVC). Ethylene-vinyl acetate infusion bags are often made in sizes ranging from 500 to 3,000 ml.
The global ethylene-vinyl acetate (EVA) infusion bag market refers to the industry that manufactures and supplies infusion bags made from ethylene-vinyl acetate copolymer. EVA infusion bags are widely used in healthcare settings for intravenous (IV) fluid administration, including the delivery of medications, nutrients, and blood products. Here鈥檚 an overview of the market:
Market Overview: The EVA infusion bag market has experienced significant growth due to the increasing demand for IV therapy, advancements in healthcare infrastructure, and a rise in chronic diseases that require long-term treatment. EVA infusion bags offer advantages such as good biocompatibility, flexibility, and transparency, making them suitable for various intravenous applications.
Material Properties: EVA is a copolymer of ethylene and vinyl acetate, and its unique properties make it an ideal material for infusion bags. EVA infusion bags have excellent flexibility, allowing easy handling and compatibility with different types of IV solutions. They are also transparent, enabling healthcare professionals to monitor the fluid level and any signs of contamination. Furthermore, EVA bags are resistant to UV radiation and have good drug compatibility.
Types of Infusion Bags: The market offers various types of EVA infusion bags, including single-chamber bags, multi-chamber bags, and specialty bags with features such as additive ports, anti-reflux valves, and hanging hooks for convenient use. Single-chamber bags are the most common type and are used for general IV fluid administration. Multi-chamber bags are designed for the sequential delivery of multiple drugs or nutrients without the need for mixing.
Market Players: The EVA infusion bag market is highly competitive, with several key players operating globally. These companies focus on product development, quality manufacturing processes, and adherence to safety standards. They also engage in collaborations, partnerships, and acquisitions to strengthen their market presence.
Market Dynamics: Factors driving the market growth include the increasing prevalence of chronic diseases, the growth of the elderly population, advancements in drug delivery systems, and the rising demand for home healthcare. Additionally, the advantages of EVA infusion bags, such as ease of use, compatibility with various drugs, and reduced risk of leaching or contamination, contribute to their popularity among healthcare professionals.
Regional Markets: The global EVA infusion bag market is segmented into regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe currently dominate the market due to well-established healthcare systems, high demand for advanced medical devices, and regulatory compliance. The market in Asia Pacific is expected to witness significant growth due to the increasing healthcare expenditure, growing awareness about IV therapy, and improving healthcare infrastructure.
Regulatory Framework: The production and sale of EVA infusion bags are subject to regulations and quality standards set by regional and national authorities. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure that these devices meet safety, quality, and performance requirements.
Market Outlook: The global EVA infusion bag market is projected to experience continued growth in the coming years. The increasing adoption of IV therapy, the rising burden of chronic diseases, and the shift towards home healthcare are expected to drive market expansion. Additionally, ongoing research and development activities to improve the biocompatibility and drug stability of EVA infusion bags will likely contribute to market growth.The global ethylene-vinyl acetate (EVA) infusion bag market refers to the industry that manufactures and supplies infusion bags made from ethylene-vinyl acetate copolymer. EVA infusion bags are widely used in healthcare settings for intravenous (IV) fluid administration, including the delivery of medications, nutrients, and blood products. Here鈥檚 an overview of the market:
Market Overview: The EVA infusion bag market has experienced significant growth due to the increasing demand for IV therapy, advancements in healthcare infrastructure, and a rise in chronic diseases that require long-term treatment. EVA infusion bags offer advantages such as good biocompatibility, flexibility, and transparency, making them suitable for various intravenous applications.
Material Properties: EVA is a copolymer of ethylene and vinyl acetate, and its unique properties make it an ideal material for infusion bags. EVA infusion bags have excellent flexibility, allowing easy handling and compatibility with different types of IV solutions. They are also transparent, enabling healthcare professionals to monitor the fluid level and any signs of contamination. Furthermore, EVA bags are resistant to UV radiation and have good drug compatibility.
Types of Infusion Bags: The market offers various types of EVA infusion bags, including single-chamber bags, multi-chamber bags, and specialty bags with features such as additive ports, anti-reflux valves, and hanging hooks for convenient use. Single-chamber bags are the most common type and are used for general IV fluid administration. Multi-chamber bags are designed for the sequential delivery of multiple drugs or nutrients without the need for mixing.
Market Players: The EVA infusion bag market is highly competitive, with several key players operating globally. These companies focus on product development, quality manufacturing processes, and adherence to safety standards. They also engage in collaborations, partnerships, and acquisitions to strengthen their market presence.
Market Dynamics: Factors driving the market growth include the increasing prevalence of chronic diseases, the growth of the elderly population, advancements in drug delivery systems, and the rising demand for home healthcare. Additionally, the advantages of EVA infusion bags, such as ease of use, compatibility with various drugs, and reduced risk of leaching or contamination, contribute to their popularity among healthcare professionals.
Regional Markets: The global EVA infusion bag market is segmented into regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe currently dominate the market due to well-established healthcare systems, high demand for advanced medical devices, and regulatory compliance. The market in Asia Pacific is expected to witness significant growth due to the increasing healthcare expenditure, growing awareness about IV therapy, and improving healthcare infrastructure.
Regulatory Framework: The production and sale of EVA infusion bags are subject to regulations and quality standards set by regional and national authorities. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure that these devices meet safety, quality, and performance requirements.
Market Outlook: The global EVA infusion bag market is projected to experience continued growth in the coming years. The increasing adoption of IV therapy, the rising burden of chronic diseases, and the shift towards home healthcare are expected to drive market expansion. Additionally, ongoing research and development activities to improve the biocompatibility and drug stability of EVA infusion bags will likely contribute to market growth.
publisher, Inc. (LPI) ' newest research report, the 鈥淓thylene-vinyl Acetate (EVA) Infusion Bag Industry Forecast鈥� looks at past sales and reviews total world Ethylene-vinyl Acetate (EVA) Infusion Bag sales in 2024, providing a comprehensive analysis by region and market sector of projected Ethylene-vinyl Acetate (EVA) Infusion Bag sales for 2025 through 2031. With Ethylene-vinyl Acetate (EVA) Infusion Bag sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ethylene-vinyl Acetate (EVA) Infusion Bag industry.
This Insight Report provides a comprehensive analysis of the global Ethylene-vinyl Acetate (EVA) Infusion Bag landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ethylene-vinyl Acetate (EVA) Infusion Bag portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ethylene-vinyl Acetate (EVA) Infusion Bag market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ethylene-vinyl Acetate (EVA) Infusion Bag and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ethylene-vinyl Acetate (EVA) Infusion Bag.
This report presents a comprehensive overview, market shares, and growth opportunities of Ethylene-vinyl Acetate (EVA) Infusion Bag market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
50 to 150 mL
150 to 500 mL
500 to 1, 500 mL
1, 500 to 3, 500 mL
Others
Segmentation by Application:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter International, Inc
ICU Medical, Inc
Fresenius Kabi, Inc
Technoflex, Inc
The Metrix Co., Inc.
McKesson Medical-Surgical, Inc.
AdvaCare Pharma LLP
Valmed, Inc
Haemotronic S.p. A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ethylene-vinyl Acetate (EVA) Infusion Bag market?
What factors are driving Ethylene-vinyl Acetate (EVA) Infusion Bag market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ethylene-vinyl Acetate (EVA) Infusion Bag market opportunities vary by end market size?
How does Ethylene-vinyl Acetate (EVA) Infusion Bag break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.